Copy number variation of the antimicrobial-gene, defensin beta 4, is associated with susceptibility to cervical cancer

Journal of Human Genetics

Volumn 58, Issue 5, 2013, Pages 250-253

  Abe, Shuhei ^a   Miura, Kiyonori ^a   Kinoshita, Akira ^a   Mishima, Hiroyuki ^a   Miura, Shoko ^a   Yamasaki, Kentaro ^a   Hasegawa, Yuri ^a   Higashijima, Ai ^a   Jo, Ozora ^a   Sasaki, Kensaku ^a   Yoshida, Atsushi ^a   Yoshiura, Koh Ichiro ^a   Masuzaki, Hideaki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

cervical cancer; copy number variation; defensin beta 4; human papillomavirus; susceptibility

Indexed keywords

BETA DEFENSIN 4;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENETIC ASSOCIATION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; UTERINE CERVIX CARCINOMA;

ADULT; BETA-DEFENSINS; CASE-CONTROL STUDIES; DNA COPY NUMBER VARIATIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84878544904     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2013.7     Document Type: Article

References (28)

1. Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720 (2003).
2. Schutte, B. C. & McCray, P. B. Jr. [Beta]-defensins in lung host defense. Annu. Rev. Physiol. 64, 709-748 (2002).
3. Horne, A. W., Stock, S. J. & King, A. E. Innate immunity and disorders of the female reproductive tract. Reproduction 135, 739-749 (2008).
4. Hollox, E. J., Armour, J. A. L. & Barber, J. C. K. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am. J. Hum. Genet. 73, 591-600 (2003).
5. Groth, M., Wiegand, C., Szafranski, K., Huse, K., Kramer, M., Rosenstile, P. et al. Both copy number and sequence variations affect expression of human DEFB4. Genes Immun. 11, 458-466 (2010).
6. Janssens, W., Nuytten, H., Dupont, L. J., Van Eldere, J., Vermeire, S., Lambrechts, D. et al. Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 182, 163-169 (2010).
7. Milanese, M., Segat, L., Arraes, L. C., Garzino-Demo, A. & Crovella, S. Copy number variation of defensin genes and HIV infection in Brazilian children. J. Acquir. Immune Defic. Syndr. 50, 331-333 (2009).
8. Sun, L., Finnegan, C. M., Kish-Catalone, T., Blumenthal, R., Garzino-Demo, P., La Terra Maggiore, G. M. et al. Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J. Virol. 79, 14318-14329 (2005).
9. Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C. & Wacholder, S. Human papillomavirus and cervical cancer. Lancet 370, 890-907 (2007).
10. Shimada, T., Miyashita, M., Miura, S., Nakayama, D., Miura, K., Fukuda, M. et al. Genital human papilloma virus infection in mentally-institutionalized virgins. Gynecol. Oncol. 106, 488-489 (2007).
11. Doorbar, J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. 110, 525-541 (2006).
12. Moscicki, A. B., Palefsky, J., Smith, G., Siboshski, S. & Schoolnik, G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet. Gynecol. 82 (Pt 1), 578-585 (1993).
13. Woodman, C. B., Collins, S., Winter, H., Bailey, A., Ellis, J., Prior, P. et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357, 1831-1836 (2001).
14. Ho, G. Y., Bierman, R., Beardsley, L., Chang, C. J. & Burk, R. D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338, 423-428 (1998).
15. Castellsague, X. & Munoz, N. Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J. Natl. Cancer Inst. Monogr. 31, 20-28 (2003).
16. Apple, R. J., Erlich, H. A., Klitz, W., Manos, M. M., Becker, T. M. & Wheeler, C. M. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat. Genet. 6, 157-162 (1994).
17. Beskow, A. H., Josefsson, A. M. & Gyllensten, U. B. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int. J. Cancer 93, 817-822 (2001).
18. Hildesheim, A. & Wang, S. S. Host and viral genetics and risk of cervical cancer: a review. Virus Res. 89, 229-240 (2002).
19. Wang, S. S. & Hildesheim, A. Viral and host factors in human papillomavirus persistence and progression. J. Natl. Cancer Inst. Monogr. 31, 35-40 (2003).
20. Matsumoto, K., Maeda, H., Oki, A., Takatsuka, N., Yasugi, T., Furuta, R. et al. HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort study. Int. J. Gynecol. Cancer 22, 471-478 (2012).
21. Perne, A., Zhang, X., Lehmann, L., Groth, M., Stuber, F. & Book, M. Comparison of multiplex ligation-dependent probe amplification and real-time PCR accuracy for gene copy number quantification using the beta-defensin locus. Biotechniques 47, 1023-1028 (2009).
22. Chen, Q., Book, M., Fang, X., Hoeft, A. & Stuber, F. Screening of copy number polymorphisms in human beta-defensin genes using modified real-time quantitative PCR. J. Immunol. Methods 308, 231-240 (2006).
23. Magnusson, P. K., Lichtenstein, P. & Gyllensten, U. B. Heritability of cervical tumours. Int. J. Cancer 88, 698-701 (2000).
24. Wang, S. S., Bratti, M. C., Rodriguez, A. C., Herrero, R., Burk, R. D., Porras, C. et al. Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J. Infect. Dis. 199, 20-30 (2009).
25. Wang, S. S., Gonzalez, P., Yu, K., Porras, C., Li, Q., Safaeian, M. et al. Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One 5, e8667 (2010).
26. Safaeian, M., Hildesheim, A., Gonzalez, P., Yu, K., Porras, C., Li, Q. et al. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. PLoS One 7, e33619 (2012).
27. Buck, C. B., Day, P. M., Thompson, C. D., Lubkowski, J., Lu, W., Lowy, D. R. et al. Human alpha-defensins block papillomavirus infection. Proc. Natl Acad. Sci. 103, 1516-1521 (2006).
28. Hardwick, R. J., Machado, L. R., Zuccherato, L. W., Antolinos, S., Xue, Y., Shawa, N. et al. A worldwide analysis of beta-defensin copy number variation suggests recent selection of a high-expressing DEFB103 gene copy in East Asia. Hum. Mutat. 32, 743-750 (2011).